WHO approves second mpox vaccine
Sign up now: Get ST's newsletters delivered to your inbox
The WHO on Nov 19 approved an mpox vaccine from Japanese pharma company KM Biologics for emergency use.
PHOTO: AFP
Follow topic:
GENEVA - The World Health Organisation (WHO) on Nov 19 approved an mpox vaccine from Japanese pharma company KM Biologics for emergency use, the second one to get the agency’s seal of approval.
The WHO said it granted emergency use listing (EUL) authorisation to the LC16m8 vaccine to “facilitate increased and timely access to vaccines in communities where mpox outbreaks are surging”.
A WHO EUL paves the way for countries worldwide to quickly approve and import the vaccine for distribution.
“WHO emergency use listing of the LC16m8 vaccine against mpox marks a significant step in our response to the current emergency, providing a new option to protect all populations, including children,” Dr Yukiko Nakatani, WHO’s assistant director-general for access to medicines and health products, said in a statement.
The WHO had already in September prequalified another vaccine against mpox, Bavarian-Nordic’s MVA-BN, in a bid to help step up the fight against swelling mpox outbreaks.
The UN health agency on Aug 14 declared a fresh international emergency over mpox, amid mounting concern over a surge in cases of the new clade Ib strain in the Democratic Republic of Congo that spread to nearby countries.
That and other mpox strains have been reported across 80 countries – 19 of them in Africa – so far in 2024, WHO said.
The DR Congo remains by far the hardest-hit country, having recorded a large majority of the more than 39,000 suspected cases and over 1,000 deaths.
WHO said that the Nov 19 announcement was particularly relevant since the Japanese government had announced it would donate 3.05 million LC16m8 doses, along with specialised inoculation needles to the DRC.
“This is the largest donation package announced to date in response to the current mpox emergency,” it said.
The WHO warned the vaccine should not be used during pregnancy or by immunocompromised persons.
Mpox, previously known as monkeypox, is caused by a virus transmitted to humans by infected animals, but can also be passed from human to human through close physical contact.
It causes fever, muscular aches and large boil-like skin lesions, and can be deadly. AFP
